{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T17:21:18Z","timestamp":1764782478027,"version":"3.41.2"},"reference-count":171,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T00:00:00Z","timestamp":1738281600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100013099","name":"Scientific Research Fund of Liaoning Provincial Education Department","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013099","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>The IL-2 family, consisting of IL-2, IL-4, IL-7, IL-9, IL-15 and IL-21, is a key regulator of the immune response. As an important endocrine and digestive organ, the function of the pancreas is regulated by the immune system. Studies have shown that each cytokine of the IL-2 family influences the occurrence and development of pancreatic diseases by participating in the regulation of the immune system. In this paper, we review the structural and functional characteristics of IL-2 family members, focus on their molecular mechanisms in pancreatic diseases including acute pancreatitis, chronic pancreatitis and pancreatic cancer, and highlight the importance of the related proteins in the regulation of immune response and disease progression, which will provide valuable insights for new biomarkers in pancreatic diseases, early diagnosis of the diseases, assessment of the disease severity, and development of new therapeutic regimens. The insights of the study are summarized in the following sections.<\/jats:p>","DOI":"10.3389\/fimmu.2025.1480496","type":"journal-article","created":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T06:43:04Z","timestamp":1738305784000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Based on the immune system: the role of the IL-2 family in pancreatic disease"],"prefix":"10.3389","volume":"16","author":[{"given":"Yuqing","family":"Zhu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zheng","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhuo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ke","family":"Ning","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,1,31]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1090311","article-title":"The application of Interleukin-2 family cytokines in tumor immunotherapy research","volume":"14","author":"Zhou","year":"2023","journal-title":"Front Immunol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.immunol.26.021607.090357","article-title":"The biology of interleukin-2","volume":"26","author":"Malek","year":"2008","journal-title":"Annu Rev Immunol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.cytogfr.2014.07.018","article-title":"The IL-2 cytokine family in cancer immunotherapy","volume":"25","author":"Sim","year":"2014","journal-title":"Cytokine Growth Factor Rev"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1080\/15548627.2019.1596486","article-title":"Impaired TFEB-mediated lysosomal biogenesis promotes the development of pancreatitis in mice and is associated with human pancreatitis","volume":"15","author":"Wang","year":"2019","journal-title":"Autophagy"},{"key":"B5","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/S0140-6736(14)60649-8","article-title":"Acute pancreatitis","volume":"386","author":"Lankisch","year":"2015","journal-title":"Lancet"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2013.01.068","article-title":"The epidemiology of pancreatitis and pancreatic cancer","volume":"144","author":"Yadav","year":"2013","journal-title":"Gastroenterology"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2019.19411","article-title":"Diagnosis and management of chronic pancreatitis: A review","volume":"322","author":"Singh","year":"2019","journal-title":"Jama"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.1053\/j.gastro.2018.11.081","article-title":"Genetics, cell biology, and pathophysiology of pancreatitis","volume":"156","author":"Mayerle","year":"2019","journal-title":"Gastroenterology"},{"key":"B9","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1517\/14728222.2015.1077227","article-title":"Therapeutic implications of innate immune system in acute pancreatitis","volume":"20","author":"Shamoon","year":"2016","journal-title":"Expert Opin Ther Targets"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2012.12.042","article-title":"Role of immune cells and immune-based therapies in pancreatitis and pancreatic ductal adenocarcinoma","volume":"144","author":"Zheng","year":"2013","journal-title":"Gastroenterology"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2019.5007","article-title":"NCCN guidelines updates: pancreatic cancer","volume":"17","author":"Tempero","year":"2019","journal-title":"J Natl Compr Canc Netw"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.21.02616","article-title":"Immunologic strategies in pancreatic cancer: making cold tumors hot","volume":"40","author":"Ullman","year":"2022","journal-title":"J Clin Oncol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.ccell.2023.02.016","article-title":"The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth","volume":"41","author":"De Visser","year":"2023","journal-title":"Cancer Cell"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1287459","article-title":"Pancreatic cancer tumor microenvironment is a major therapeutic barrier and target","volume":"15","author":"Hartupee","year":"2024","journal-title":"Front Immunol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-021-00363-z","article-title":"Interleukins in cancer: from biology to therapy","volume":"21","author":"Briukhovetska","year":"2021","journal-title":"Nat Rev Cancer"},{"key":"B16","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/j.jaci.2010.11.050","article-title":"Interleukins, from 1 to 37, and interferon-\u03b3: receptors, functions, and roles in diseases","volume":"127","author":"Akdis","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.87.18.6934","article-title":"Structural design and molecular evolution of a cytokine receptor superfamily","volume":"87","author":"Bazan","year":"1990","journal-title":"Proc Natl Acad Sci U.S.A"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2019.03.028","article-title":"The \u03b3(c) family of cytokines: basic biology to therapeutic ramifications","volume":"50","author":"Leonard","year":"2019","journal-title":"Immunity"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-042617-053352","article-title":"Signaling and function of interleukin-2 in T lymphocytes","volume":"36","author":"Ross","year":"2018","journal-title":"Annu Rev Immunol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1126\/science.181845","article-title":"Selective in vitro growth of T lymphocytes from normal human bone marrows","volume":"193","author":"Morgan","year":"1976","journal-title":"Science"},{"key":"B21","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1016\/j.coi.2011.08.003","article-title":"IL-2 family cytokines: new insights into the complex roles of IL-2 as a broad regulator of T helper cell differentiation","volume":"23","author":"Liao","year":"2011","journal-title":"Curr Opin Immunol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.aat1482","article-title":"Revisiting IL-2: Biology and therapeutic prospects","volume":"3","author":"Abbas","year":"2018","journal-title":"Sci Immunol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"2998","DOI":"10.3390\/ijms22062998","article-title":"Involvement of IL-4, IL-13 and their receptors in pancreatic cancer","volume":"22","author":"Shi","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2018.10.204","article-title":"Characterization of cryptic allosteric site at IL-4R\u03b1: New paradigm towards IL-4\/IL-4R inhibition","volume":"123","author":"Naz","year":"2019","journal-title":"Int J Biol Macromol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1016\/0092-8674(87)90708-2","article-title":"A single bone marrow-derived stromal cell type supports the in vitro growth of early lymphoid and myeloid cells","volume":"48","author":"Hunt","year":"1987","journal-title":"Cell"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.cytogfr.2005.05.004","article-title":"Cell biology of IL-7, a key lymphotrophin","volume":"16","author":"Jiang","year":"2005","journal-title":"Cytokine Growth Factor Rev"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2005.01.004","article-title":"IL-7: maintaining T-cell memory and achieving homeostasis","volume":"26","author":"Bradley","year":"2005","journal-title":"Trends Immunol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2249.2002.02015.x","article-title":"Expansion of activated human na\u00efve T-cells precedes effector function","volume":"130","author":"Brenchley","year":"2002","journal-title":"Clin Exp Immunol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.747324","article-title":"Interleukin-7 biology and its effects on immune cells: mediator of generation, differentiation, survival, and homeostasis","volume":"12","author":"Chen","year":"2021","journal-title":"Front Immunol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.85.18.6934","article-title":"Functional and structural characterization of P40, a mouse glycoprotein with T-cell growth factor activity","volume":"85","author":"Uyttenhove","year":"1988","journal-title":"Proc Natl Acad Sci U.S.A"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1016\/j.jaci.2018.06.046","article-title":"B lymphocyte-induced maturation protein 1 controls T(H)9 cell development, IL-9 production, and allergic inflammation","volume":"143","author":"Benevides","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"2113","DOI":"10.3390\/ijms20092113","article-title":"An update on interleukin-9: from its cellular source and signal transduction to its role in immunopathogenesis","volume":"20","author":"Chakraborty","year":"2019","journal-title":"Int J Mol Sci"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1084\/jem.180.4.1395","article-title":"Interleukin (IL) 15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor","volume":"180","author":"Carson","year":"1994","journal-title":"J Exp Med"},{"key":"B34","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1038\/nri1901","article-title":"The biology of interleukin-2 and interleukin-15: implications for cancer therapy and vaccine design","volume":"6","author":"Waldmann","year":"2006","journal-title":"Nat Rev Immunol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20191062","article-title":"Interleukin-15 (dys)regulation of lymphoid homeostasis: Implications for therapy of autoimmunity and cancer","volume":"217","author":"Waldmann","year":"2020","journal-title":"J Exp Med"},{"key":"B36","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1182\/blood.V97.1.14","article-title":"Interleukin 15: biology and relevance to human disease","volume":"97","author":"Fehniger","year":"2001","journal-title":"Blood"},{"key":"B37","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1146\/annurev.immunol.17.1.19","article-title":"The multifaceted regulation of interleukin-15 expression and the role of this cytokine in NK cell differentiation and host response to intracellular pathogens","volume":"17","author":"Waldmann","year":"1999","journal-title":"Annu Rev Immunol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00868","article-title":"IL-15 in the combination immunotherapy of cancer","volume":"11","author":"Waldmann","year":"2020","journal-title":"Front Immunol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.180.7.4391","article-title":"IL-15 transpresentation augments CD8+ T cell activation and is required for optimal recall responses by central memory CD8+ T cells","volume":"180","author":"Kokaji","year":"2008","journal-title":"J Immunol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/35040504","article-title":"Interleukin 21 and its receptor are involved in NK cell expansion and regulation of lymphocyte function","volume":"408","author":"Parrish-Novak","year":"2000","journal-title":"Nature"},{"key":"B41","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1146\/annurev.immunol.26.021607.090316","article-title":"Interleukin-21: basic biology and implications for cancer and autoimmunity","volume":"26","author":"Spolski","year":"2008","journal-title":"Annu Rev Immunol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jaut.2019.01.013","article-title":"Clinical significance and immunobiology of IL-21 in autoimmunity","volume":"99","author":"Long","year":"2019","journal-title":"J Autoimmun"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-041015-055605","article-title":"Follicular helper T cells","volume":"34","author":"Vinuesa","year":"2016","journal-title":"Annu Rev Immunol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-020711-075032","article-title":"Germinal centers","volume":"30","author":"Victora","year":"2012","journal-title":"Annu Rev Immunol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-019-0158-2","article-title":"New insights into acute pancreatitis","volume":"16","author":"Lee","year":"2019","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"8630","DOI":"10.3390\/molecules27238630","article-title":"Effects of berberine against pancreatitis and pancreatic cancer","volume":"27","author":"Vlavcheski","year":"2022","journal-title":"Molecules"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2021.10.017","article-title":"Burden and cost of gastrointestinal, liver, and pancreatic diseases in the United States: update 2021","volume":"162","author":"Peery","year":"2022","journal-title":"Gastroenterology"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.20317","article-title":"Acute pancreatitis: A review","volume":"325","author":"Mederos","year":"2021","journal-title":"Jama"},{"key":"B49","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/S0140-6736(20)31318-0","article-title":"Chronic pancreatitis","volume":"396","author":"Beyer","year":"2020","journal-title":"Lancet"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2017.08.071","article-title":"Autophagy, inflammation, and immune dysfunction in the pathogenesis of pancreatitis","volume":"153","author":"Gukovskaya","year":"2017","journal-title":"Gastroenterology"},{"key":"B51","doi-asserted-by":"publisher","first-page":"110693","DOI":"10.1016\/j.biopha.2020.110693","article-title":"Macrophages in pancreatitis: Mechanisms and therapeutic potential","volume":"131","author":"Hu","year":"2020","journal-title":"BioMed Pharmacother"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1097\/MPA.0000000000000886","article-title":"Inflammation-related pancreatic carcinogenesis: mechanisms and clinical potentials in advances","volume":"46","author":"Dai","year":"2017","journal-title":"Pancreas"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1055\/s-0030-1255354","article-title":"Macrophages: master regulators of inflammation and fibrosis","volume":"30","author":"Wynn","year":"2010","journal-title":"Semin Liver Dis"},{"key":"B54","doi-asserted-by":"publisher","first-page":"7158","DOI":"10.1038\/ncomms8158","article-title":"Alternatively activated macrophages promote pancreatic fibrosis in chronic pancreatitis","volume":"6","author":"Xue","year":"2015","journal-title":"Nat Commun"},{"key":"B55","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/s41575-021-00457-x","article-title":"Pancreatic cancer epidemiology: understanding the role of lifestyle and inherited risk factors","volume":"18","author":"Klein","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1016\/j.dld.2017.07.001","article-title":"Incidence of and risk factors for pancreatic cancer in chronic pancreatitis: A cohort of 1656 patients","volume":"49","author":"Hao","year":"2017","journal-title":"Dig Liver Dis"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2013.08.014","article-title":"Molecular mechanisms underlying chronic inflammation-associated cancers","volume":"345","author":"Wu","year":"2014","journal-title":"Cancer Lett"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2012.07.024","article-title":"EGF receptor is required for KRAS-induced pancreatic tumorigenesis","volume":"22","author":"Ardito","year":"2012","journal-title":"Cancer Cell"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1097\/MPA.0000000000000527","article-title":"Symptoms of pancreatic cancer in primary care: A systematic review","volume":"45","author":"Schmidt-Hansen","year":"2016","journal-title":"Pancreas"},{"key":"B60","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1053\/j.gastro.2013.11.004","article-title":"Pancreatic ductal adenocarcinoma radiology reporting template: consensus statement of the society of abdominal radiology and the american pancreatic association","volume":"146","author":"Al-Hawary","year":"2014","journal-title":"Gastroenterology"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.3978\/j.issn.2078-6891.2011.021","article-title":"The clinical utility of serum CA 19-9 in the diagnosis, prognosis and management of pancreatic adenocarcinoma: An evidence based appraisal","volume":"3","author":"Ballehaninna","year":"2012","journal-title":"J Gastrointest Oncol"},{"key":"B62","doi-asserted-by":"publisher","first-page":"7307","DOI":"10.3390\/ijms21197307","article-title":"The immune microenvironment in pancreatic cancer","volume":"21","author":"Huber","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B63","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.canlet.2021.01.031","article-title":"Trials and tribulations of pancreatic cancer immunotherapy","volume":"504","author":"Principe","year":"2021","journal-title":"Cancer Lett"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.immunol.25.022106.141623","article-title":"Regulatory T cells: mechanisms of differentiation and function","volume":"30","author":"Josefowicz","year":"2012","journal-title":"Annu Rev Immunol"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(93)80067-O","article-title":"Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene","volume":"75","author":"Sadlack","year":"1993","journal-title":"Cell"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1126\/science.7770771","article-title":"Deregulated T cell activation and autoimmunity in mice lacking interleukin-2 receptor beta","volume":"268","author":"Suzuki","year":"1995","journal-title":"Science"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1016\/1074-7613(95)90180-9","article-title":"Interleukin-2 receptor alpha chain regulates the size and content of the peripheral lymphoid compartment","volume":"3","author":"Willerford","year":"1995","journal-title":"Immunity"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20182304","article-title":"Human interleukin-2 receptor \u03b2 mutations associated with defects in immunity and peripheral tolerance","volume":"216","author":"Zhang","year":"2019","journal-title":"J Exp Med"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.94.7.3168","article-title":"Human immune disorder arising from mutation of the alpha chain of the interleukin-2 receptor","volume":"94","author":"Sharfe","year":"1997","journal-title":"Proc Natl Acad Sci U.S.A"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2019.03.064","article-title":"New therapeutic strategies based on IL-2 to modulate Treg cells for autoimmune diseases","volume":"72","author":"Xu","year":"2019","journal-title":"Int Immunopharmacol"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1038\/nri3156","article-title":"The role of interleukin-2 during homeostasis and activation of the immune system","volume":"12","author":"Boyman","year":"2012","journal-title":"Nat Rev Immunol"},{"key":"B72","doi-asserted-by":"publisher","first-page":"4502","DOI":"10.1038\/s41467-022-32195-2","article-title":"In mouse chronic pancreatitis CD25(+)FOXP3(+) regulatory T cells control pancreatic fibrosis by suppression of the type 2 immune response","volume":"13","author":"Glaubitz","year":"2022","journal-title":"Nat Commun"},{"key":"B73","doi-asserted-by":"publisher","first-page":"114212","DOI":"10.1016\/j.biopha.2022.114212","article-title":"TGF-\u03b22 antisense oligonucleotide enhances T-cell mediated anti-tumor activities by IL-2 via attenuation of fibrotic reaction in a humanized mouse model of pancreatic ductal adenocarcinoma","volume":"159","author":"Lee","year":"2023","journal-title":"BioMed Pharmacother"},{"key":"B74","doi-asserted-by":"publisher","first-page":"4077","DOI":"10.1038\/s41467-021-24331-1","article-title":"Microbial short-chain fatty acids modulate CD8(+) T cell responses and improve adoptive immunotherapy for cancer","volume":"12","author":"Luu","year":"2021","journal-title":"Nat Commun"},{"key":"B75","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1007\/s00262-024-03669-7","article-title":"IL-2 promotes expansion and intratumoral accumulation of tumor infiltrating dendritic cells in pancreatic cancer","volume":"73","author":"Gong","year":"2024","journal-title":"Cancer Immunol Immunother"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aba5464","article-title":"Interleukin-2 signals converge in a lymphoid-dendritic cell pathway that promotes anticancer immunity","volume":"12","author":"Raeber","year":"2020","journal-title":"Sci\u00a0Transl Med"},{"key":"B77","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1097\/CJI.0000000000000230","article-title":"Utilizing T-cell activation signals 1, 2, and 3 for tumor-infiltrating lymphocytes (TIL) expansion: the advantage over the sole use of interleukin-2 in cutaneous and uveal melanoma","volume":"41","author":"Tavera","year":"2018","journal-title":"J Immunother"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2023-006822","article-title":"Efficacy and safety of autologous tumor-infiltrating lymphocytes in recurrent or refractory ovarian cancer, colorectal cancer, and pancreatic ductal adenocarcinoma","volume":"12","author":"Amaria","year":"2024","journal-title":"J Immunother Cancer"},{"key":"B79","doi-asserted-by":"publisher","first-page":"3874","DOI":"10.1038\/s41467-019-11782-w","article-title":"A next-generation tumor-targeting IL-2 preferentially promotes tumor-infiltrating CD8(+) T-cell response and effective tumor control","volume":"10","author":"Sun","year":"2019","journal-title":"Nat Commun"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1002\/ptr.v38.7","article-title":"Salvianolic acid B alleviates autoimmunity in Treg-deficient mice via inhibiting IL2-STAT5 signaling","volume":"38","author":"Wang","year":"2024","journal-title":"Phytother Res"},{"key":"B81","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1158\/2326-6066.CIR-23-0145","article-title":"IL18 at the crossroads between chronic inflammation and T-cell exhaustion in pancreatic cancer","volume":"11","author":"Stromnes","year":"2023","journal-title":"Cancer Immunol Res"},{"key":"B82","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1016\/j.tcb.2020.06.003","article-title":"The roles of CD8(+) T cell subsets in antitumor immunity","volume":"30","author":"St Paul","year":"2020","journal-title":"Trends Cell Biol"},{"key":"B83","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/s40001-024-01711-z","article-title":"The paradoxical role of cytokines and chemokines at the tumor microenvironment: a comprehensive review","volume":"29","author":"Abdul-Rahman","year":"2024","journal-title":"Eur J Med Res"},{"key":"B84","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1016\/j.ccell.2023.04.001","article-title":"Simultaneous targeting of PD-1 and IL-2R\u03b2\u03b3 with radiation therapy inhibits pancreatic cancer growth and metastasis","volume":"41","author":"Piper","year":"2023","journal-title":"Cancer Cell"},{"key":"B85","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.immuni.2022.12.006","article-title":"Bispecific PD1-IL2v and anti-PD-L1 break tumor immunity resistance by enhancing stem-like tumor-reactive CD8(+) T cells and reprogramming macrophages","volume":"56","author":"Tichet","year":"2023","journal-title":"Immunity"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1007\/s11033-013-2766-1","article-title":"Effect of combined treatment with recombinant interleukin-2 and allicin on pancreatic cancer","volume":"40","author":"Wang","year":"2013","journal-title":"Mol Biol Rep"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1007\/s40264-014-0226-z","article-title":"Side effects of cytokines approved for therapy","volume":"37","author":"Baldo","year":"2014","journal-title":"Drug Saf"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1093\/cei\/uxac105","article-title":"IL-2-based approaches to Treg enhancement","volume":"211","author":"Harris","year":"2023","journal-title":"Clin Exp Immunol"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1016\/j.pan.2021.09.016","article-title":"Serum biomarkers for chronic pancreatitis pain patterns","volume":"21","author":"Saloman","year":"2021","journal-title":"Pancreatology"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1067\/msy.2000.101584","article-title":"Inflammatory cytokines and cell response in surgery","volume":"127","author":"Lin","year":"2000","journal-title":"Surgery"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2021-002865","article-title":"High-dose IL-2\/CD25 fusion protein amplifies vaccine-induced CD4(+) and CD8(+) neoantigen-specific T cells to promote antitumor immunity","volume":"9","author":"Hernandez","year":"2021","journal-title":"J Immunother Cancer"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v23.i8.1367","article-title":"Pharmacokinetics and pharmacodynamics of Da-Cheng-Qi decoction in the liver of rats with severe acute pancreatitis","volume":"23","author":"Zhang","year":"2017","journal-title":"World J Gastroenterol"},{"key":"B93","doi-asserted-by":"publisher","first-page":"108315","DOI":"10.1016\/j.intimp.2021.108315","article-title":"Baicalein alleviates pyroptosis and inflammation in hyperlipidemic pancreatitis by inhibiting NLRP3\/Caspase-1 pathway through the miR-192-5p\/TXNIP axis","volume":"101","author":"Wang","year":"2021","journal-title":"Int Immunopharmacol"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v22.i42.9368","article-title":"IRF5 regulates lung macrophages M2 polarization during severe acute pancreatitis in vitro","volume":"22","author":"Sun","year":"2016","journal-title":"World J Gastroenterol"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v11.i43.6770","article-title":"Effect of IL-4 on altered expression of complement activation regulators in rat pancreatic cells during severe acute pancreatitis","volume":"11","author":"Zhang","year":"2005","journal-title":"World J Gastroenterol"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.1999.00354.x","article-title":"Interleukin-4 ameliorates crescentic glomerulonephritis in Wistar Kyoto rats","volume":"55","author":"Cook","year":"1999","journal-title":"Kidney Int"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.86.10.3803","article-title":"Potential antiinflammatory effects of interleukin 4: suppression of human monocyte tumor necrosis factor alpha, interleukin 1, and prostaglandin E2","volume":"86","author":"Hart","year":"1989","journal-title":"Proc Natl Acad Sci U.S.A"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.89.9.4076","article-title":"Coordinated antiinflammatory effects of interleukin 4: interleukin 4 suppresses interleukin 1 production but up-regulates gene expression and synthesis of interleukin 1 receptor antagonist","volume":"89","author":"Vannier","year":"1992","journal-title":"Proc Natl Acad Sci U.S.A"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1994.280","article-title":"Co-regulated expression of glomerular 12\/15-lipoxygenase and interleukin-4 mRNAs in rat nephrotoxic nephritis","volume":"46","author":"Katoh","year":"1994","journal-title":"Kidney Int"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1805288115","article-title":"Interleukin 4 is inactivated via selective disulfide-bond reduction by extracellular thioredoxin","volume":"115","author":"Plugis","year":"2018","journal-title":"Proc Natl Acad Sci U.S.A"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1111\/j.1582-4934.2006.tb00532.x","article-title":"Adenovirus-mediated gene transfer of interleukin-4 into pancreatic stellate cells promotes interleukin-10 expression","volume":"10","author":"Brock","year":"2006","journal-title":"J Cell Mol Med"},{"key":"B102","doi-asserted-by":"publisher","first-page":"e1322242","DOI":"10.1080\/2162402X.2017.1322242","article-title":"A circulating T(H)2 cytokines profile predicts survival in patients with resectable pancreatic adenocarcinoma","volume":"6","author":"Piro","year":"2017","journal-title":"Oncoimmunology"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1101\/gad.1874010","article-title":"IL-4 induces cathepsin protease activity in tumor-associated macrophages to promote cancer growth and invasion","volume":"24","author":"Gocheva","year":"2010","journal-title":"Genes Dev"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1038\/labinvest.2013.69","article-title":"M2-polarized tumor-associated macrophages promoted epithelial-mesenchymal transition in pancreatic cancer cells, partially through TLR4\/IL-10 signaling pathway","volume":"93","author":"Liu","year":"2013","journal-title":"Lab Invest"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6602416","article-title":"Interleukin-4 enhances proliferation of human pancreatic cancer cells: evidence for autocrine and paracrine actions","volume":"92","author":"Prokopchuk","year":"2005","journal-title":"Br J Cancer"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1800469","article-title":"IL-4 and IL-17A cooperatively promote hydrogen peroxide production, oxidative DNA damage, and upregulation of dual oxidase 2 in human colon and pancreatic cancer cells","volume":"203","author":"Wu","year":"2019","journal-title":"J\u00a0Immunol"},{"key":"B107","doi-asserted-by":"publisher","first-page":"108076","DOI":"10.1016\/j.abb.2019.108076","article-title":"Hydrogen peroxide-producing NADPH oxidases and the promotion of migratory phenotypes in cancer","volume":"675","author":"Meitzler","year":"2019","journal-title":"Arch Biochem Biophys"},{"key":"B108","article-title":"Enhanced expression of the insulin receptor substrate-2 docking protein in human pancreatic cancer","volume":"58","author":"Kornmann","year":"1998","journal-title":"Cancer Res"},{"key":"B109","doi-asserted-by":"publisher","first-page":"716","DOI":"10.3390\/ijms18040716","article-title":"Endogenously expressed IL-4R\u03b1 Promotes the Malignant phenotype of human pancreatic cancer in vitro and in vivo","volume":"18","author":"Traub","year":"2017","journal-title":"Int J Mol Sci"},{"key":"B110","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1593\/neo.91196","article-title":"A novel small molecule, LLL12, inhibits STAT3 phosphorylation and activities and exhibits potent growth-suppressive activity in human cancer cells","volume":"12","author":"Lin","year":"2010","journal-title":"Neoplasia"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2016.10.016","article-title":"Improving chimeric antigen receptor-modified T cell function by reversing the immunosuppressive tumor microenvironment of pancreatic cancer","volume":"25","author":"Mohammed","year":"2017","journal-title":"Mol Ther"},{"key":"B112","doi-asserted-by":"publisher","first-page":"115740","DOI":"10.1016\/j.biopha.2023.115740","article-title":"Co-expression of IL-4\/IL-15-based inverted cytokine receptor in CAR-T cells overcomes IL-4 signaling in immunosuppressive pancreatic tumor microenvironment","volume":"168","author":"Zhou","year":"2023","journal-title":"BioMed Pharmacother"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01691","article-title":"An IL-4\/21 inverted cytokine receptor improving CAR-T cell potency in immunosuppressive solid-tumor microenvironment","volume":"10","author":"Wang","year":"2019","journal-title":"Front Immunol"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellimm.2016.09.002","article-title":"Inducing a humoral immune response to pancreatic cancer antigen","volume":"310","author":"Seifert","year":"2016","journal-title":"Cell Immunol"},{"key":"B115","article-title":"Pancreatic cancer cells express interleukin-13 and -4 receptors, and their growth is inhibited by Pseudomonas exotoxin coupled to interleukin-13 and -4","volume":"19","author":"Kornmann","year":"1999","journal-title":"Anticancer Res"},{"key":"B116","article-title":"Targeting interleukin-4 receptors for effective pancreatic cancer therapy","volume":"62","author":"Kawakami","year":"2002","journal-title":"Cancer Res"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-06-4558","article-title":"Interleukin-4 cytotoxin therapy synergizes with gemcitabine in a mouse model of pancreatic ductal adenocarcinoma","volume":"67","author":"Shimamura","year":"2007","journal-title":"Cancer Res"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-11-0363","article-title":"Targeting interleukin-4 receptor \u03b1 with hybrid peptide for effective cancer therapy","volume":"11","author":"Yang","year":"2012","journal-title":"Mol Cancer Ther"},{"key":"B119","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1080\/01635581.2017.1247885","article-title":"IL-4 mRNA is downregulated in the liver of pancreatic cancer patients suffering from cachexia","volume":"69","author":"Prokopchuk","year":"2017","journal-title":"Nutr Cancer"},{"key":"B120","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1002\/jcsm.12539","article-title":"Interleukin-4 administration improves muscle function, adult myogenesis, and lifespan of colon carcinoma-bearing mice","volume":"11","author":"Costamagna","year":"2020","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.898498","article-title":"Serum cytokine levels are associated with tumor progression during FOLFIRINOX chemotherapy and overall survival in pancreatic cancer patients","volume":"13","author":"Van Der Sijde","year":"2022","journal-title":"Front Immunol"},{"key":"B122","doi-asserted-by":"publisher","first-page":"7318","DOI":"10.1038\/s41598-019-43846-8","article-title":"Systemic inflammation contributes to impairment of quality of life in chronic pancreatitis","volume":"9","author":"Robinson","year":"2019","journal-title":"Sci Rep"},{"key":"B123","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1007\/s11892-016-0731-9","article-title":"Targeting homeostatic T cell proliferation to control beta-cell autoimmunity","volume":"16","author":"Vignali","year":"2016","journal-title":"Curr Diabetes Rep"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.824746","article-title":"Microbial protein binding to gC1qR drives PLA2G1B-induced CD4 T-cell anergy","volume":"13","author":"Pothlichet","year":"2022","journal-title":"Front Immunol"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-023-03458-8","article-title":"Improved predictability of pancreatic ductal adenocarcinoma diagnosis using a blood immune cell biomarker panel developed from bulk mRNA sequencing and single-cell RNA-sequencing","volume":"72","author":"Jang","year":"2023","journal-title":"Cancer Immunol Immunother"},{"key":"B126","doi-asserted-by":"publisher","first-page":"4157","DOI":"10.3390\/jcm10184157","article-title":"Characterization of circulating IL-7R positive cell populations for early detection of pancreatic ductal adenocarcinoma","volume":"10","author":"Heo","year":"2021","journal-title":"J Clin Med"},{"key":"B127","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1186\/s12967-017-1227-3","article-title":"Distinct pathophysiological cytokine profiles for discrimination between autoimmune pancreatitis, chronic pancreatitis, and pancreatic ductal adenocarcinoma","volume":"15","author":"Ghassem-Zadeh","year":"2017","journal-title":"J Transl Med"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1172\/JCI130189","article-title":"Glucocorticoids paradoxically facilitate steroid resistance in T cell acute lymphoblastic leukemias and thymocytes","volume":"130","author":"Meyer","year":"2020","journal-title":"J Clin Invest"},{"key":"B129","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1038\/s41392-021-00492-9","article-title":"The lncRNA Snhg1-Vps13D vesicle trafficking system promotes memory CD8 T cell establishment via regulating the dual effects of IL-7 signaling","volume":"6","author":"Zhang","year":"2021","journal-title":"Signal Transduct Target Ther"},{"key":"B130","doi-asserted-by":"publisher","first-page":"10412","DOI":"10.3390\/ijms231810412","article-title":"The role of IL-7 and IL-7R in cancer pathophysiology and immunotherapy","volume":"23","author":"Wang","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B131","doi-asserted-by":"publisher","first-page":"599","DOI":"10.20892\/j.issn.2095-3941.2023.0039","article-title":"Nuclear PLD1 combined with NPM1 induces gemcitabine resistance through tumorigenic IL7R in pancreatic adenocarcinoma","volume":"20","author":"Fu","year":"2023","journal-title":"Cancer Biol Med"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e32834a3678","article-title":"HIV infection perturbs interleukin-7 signaling at the step of STAT5 nuclear relocalization","volume":"25","author":"Landires","year":"2011","journal-title":"Aids"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.1172\/JCI131842","article-title":"PLA2G1B is involved in CD4 anergy and CD4 lymphopenia in HIV-infected patients","volume":"130","author":"Pothlichet","year":"2020","journal-title":"J Clin Invest"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1510045112","article-title":"IL-7R signaling in regulatory T cells maintains peripheral and allograft tolerance in mice","volume":"112","author":"Schmaler","year":"2015","journal-title":"Proc Natl Acad Sci U.S.A"},{"key":"B135","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1186\/s13045-021-01128-9","article-title":"IL-7 and CCL19-secreting CAR-T cell therapy for tumors with positive glypican-3 or mesothelin","volume":"14","author":"Pang","year":"2021","journal-title":"J Hematol Oncol"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2024-008989","article-title":"rhIL-7-hyFc, a long-acting interleukin-7, improves efficacy of CAR-T cell therapy in solid tumors","volume":"12","author":"Li","year":"2024","journal-title":"J Immunother Cancer"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.2119\/molmed.2016.00034","article-title":"Spautin-1 ameliorates acute pancreatitis via inhibiting impaired autophagy and alleviating calcium overload","volume":"22","author":"Xiao","year":"2016","journal-title":"Mol Med"},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.00859","article-title":"Mogroside II(E) inhibits digestive enzymes via suppression of interleukin 9\/interleukin 9 receptor signalling in acute pancreatitis","volume":"11","author":"Xiao","year":"2020","journal-title":"Front Pharmacol"},{"key":"B139","doi-asserted-by":"publisher","first-page":"2831056","DOI":"10.1155\/2017\/2831056","article-title":"Interleukin-9 Promotes Pancreatic Cancer Cells Proliferation and Migration via the miR-200a\/Beta-Catenin Axis","volume":"2017","author":"Hu","year":"2017","journal-title":"BioMed Res Int"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.17219\/acem\/104543","article-title":"Targeted blockade of interleukin 9 inhibits tumor growth in murine model of pancreatic cancer","volume":"28","author":"Lu","year":"2019","journal-title":"Adv Clin Exp Med"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2017.08.031","article-title":"Th9 cells promote antitumor immunity via IL-9 and IL-21 and demonstrate atypical cytokine expression in breast cancer","volume":"52","author":"You","year":"2017","journal-title":"Int Immunopharmacol"},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201207-1307OC","article-title":"Differentiation and immune regulation of IL-9-producing CD4+ T cells in Malignant pleural effusion","volume":"186","author":"Ye","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.947407","article-title":"Immune features of the peritumoral stroma in pancreatic ductal adenocarcinoma","volume":"13","author":"Ahmed","year":"2022","journal-title":"Front Immunol"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01026","article-title":"Th9 cell differentiation and its dual effects in tumor development","volume":"11","author":"Chen","year":"2020","journal-title":"Front Immunol"},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.1002\/eji.201041125","article-title":"IL-9 is important for T-cell activation and differentiation in autoimmune inflammation of the central nervous system","volume":"41","author":"Li","year":"2011","journal-title":"Eur J Immunol"},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-022-04801-2","article-title":"Potentiating adoptive cell therapy using synthetic IL-9 receptors","volume":"607","author":"Kalbasi","year":"2022","journal-title":"Nature"},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.1016\/j.surg.2007.05.002","article-title":"Serum interleukin-15 level is a useful predictor of the complications and mortality in severe acute pancreatitis","volume":"142","author":"Ueda","year":"2007","journal-title":"Surgery"},{"key":"B148","doi-asserted-by":"publisher","DOI":"10.1097\/SHK.0000000000001352","article-title":"IL-15 improves aging-induced persistent T cell exhaustion in mouse models of repeated sepsis","volume":"53","author":"Saito","year":"2020","journal-title":"Shock"},{"key":"B149","doi-asserted-by":"publisher","DOI":"10.1152\/ajpgi.00139.2018","article-title":"IL-15 regulates fibrosis and inflammation in a mouse model of chronic pancreatitis","volume":"315","author":"Manohar","year":"2018","journal-title":"Am J Physiology-Gastrointestinal Liver Physiol"},{"key":"B150","doi-asserted-by":"publisher","first-page":"119640","DOI":"10.1016\/j.lfs.2021.119640","article-title":"Chronic inflammation promotes epithelial-mesenchymal transition-mediated Malignant phenotypes and lung injury in experimentally-induced pancreatitis","volume":"278","author":"Kandikattu","year":"2021","journal-title":"Life Sci"},{"key":"B151","doi-asserted-by":"publisher","first-page":"e0262439","DOI":"10.1371\/journal.pone.0262439","article-title":"Pancreatic ductal adenocarcinoma: Prognostic indicators of advanced disease","volume":"17","author":"Kruger","year":"2022","journal-title":"PloS One"},{"key":"B152","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a028472","article-title":"Cytokines in cancer immunotherapy","volume":"10","author":"Waldmann","year":"2018","journal-title":"Cold Spring Harbor Perspect Biol"},{"key":"B153","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20191062","article-title":"Regulation of Lymphoid Homeostasis: Implications for Therapy of Autoimmunity and Cancer","volume":"217","author":"Waldmann","year":"2020","journal-title":"J Exp Med"},{"key":"B154","doi-asserted-by":"publisher","DOI":"10.26355\/eurrev_202108_26519","article-title":"Combination therapy with interleukin-15 and metformin as a synergistic treatment for pancreatic cancer","volume":"25","author":"Shi","year":"2021","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"B155","doi-asserted-by":"publisher","first-page":"e1165","DOI":"10.1002\/cti2.1165","article-title":"Novel combination immunotherapy for pancreatic cancer: potent anti-tumor effects with CD40 agonist and interleukin-15 treatment","volume":"9","author":"Van Audenaerde","year":"2020","journal-title":"Clin Transl Immunol"},{"key":"B156","doi-asserted-by":"publisher","DOI":"10.1080\/14712598.2020.1738379","article-title":"Rationale for IL-15 superagonists in cancer immunotherapy","volume":"20","author":"Knudson","year":"2020","journal-title":"Expert Opin Biol Ther"},{"key":"B157","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.17220","article-title":"Synergistic effect of Abraxane that combines human IL15 fused with an albumin-binding domain on murine models of pancreatic ductal adenocarcinoma","volume":"26","author":"Hsu","year":"2022","journal-title":"J Cell Mol Med"},{"key":"B158","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2021-003923","article-title":"Natural killer T cell immunotherapy combined with IL-15-expressing oncolytic virotherapy and PD-1 blockade mediates pancreatic tumor regression","volume":"10","author":"Nelson","year":"2022","journal-title":"J Immunother Cancer"},{"key":"B159","doi-asserted-by":"publisher","first-page":"122453","DOI":"10.1016\/j.biomaterials.2023.122453","article-title":"Dual-crosslinking immunostimulatory hydrogel synchronously suppresses pancreatic fistula and pancreatic cancer relapse post-resection","volume":"305","author":"Zhao","year":"2024","journal-title":"Biomaterials"},{"key":"B160","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s13045-024-01525-w","article-title":"IL-15-secreting CAR natural killer cells directed toward the pan-cancer target CD70 eliminate both cancer cells and cancer-associated fibroblasts","volume":"17","author":"Van Den Eynde","year":"2024","journal-title":"J Hematol Oncol"},{"key":"B161","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/j.stem.2024.03.018","article-title":"Human anti-PSCA CAR macrophages possess potent antitumor activity against pancreatic cancer","volume":"31","author":"Shah","year":"2024","journal-title":"Cell Stem Cell"},{"key":"B162","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2021.12.281","article-title":"Off-the-shelf prostate stem cell antigen-directed chimeric antigen receptor natural killer cell therapy to treat pancreatic cancer","volume":"162","author":"Teng","year":"2022","journal-title":"Gastroenterology"},{"key":"B163","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.726985","article-title":"A novel sushi-IL15-PD1 CAR-NK92 cell line with enhanced and PD-L1 targeted cytotoxicity against pancreatic cancer cells","volume":"12","author":"Xu","year":"2022","journal-title":"Front Oncol"},{"key":"B164","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2022.05.006","article-title":"Exercise-induced engagement of the IL-15\/1L-15R\u03b1 axis promotes anti-tumor immunity in pancreatic cancer","volume":"40","author":"Kurz","year":"2022","journal-title":"Cancer Cell"},{"key":"B165","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.c.7451282.v1","article-title":"Physical activity decreases inflammation and delays development of obesity-associated pancreatic ductal adenocarcinoma","volume":"84","author":"Pita-Grisanti","year":"2024","journal-title":"Cancer Res"},{"key":"B166","doi-asserted-by":"publisher","DOI":"10.1038\/sj.cgt.7700630","article-title":"Transduction of the IL-21 and IL-23 genes in human pancreatic carcinoma cells produces natural killer cell-dependent and -independent antitumor effects","volume":"10","author":"Ugai","year":"2003","journal-title":"Cancer Gene Ther"},{"key":"B167","doi-asserted-by":"publisher","first-page":"3678","DOI":"10.3390\/cancers13153678","article-title":"Follicular helper T cells remodel the immune microenvironment of pancreatic cancer via secreting CXCL13 and IL-21","volume":"13","author":"Lin","year":"2021","journal-title":"Cancers (Basel)"},{"key":"B168","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s12943-024-02023-w","article-title":"Regulatory mechanisms of PD-1\/PD-L1 in cancers","volume":"23","author":"Lin","year":"2024","journal-title":"Mol Cancer"},{"key":"B169","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1158\/1078-0432.CCR-16-0004","article-title":"IL-21 enhances natural killer cell response to cetuximab-coated pancreatic tumor cells","volume":"23","author":"Mcmichael","year":"2017","journal-title":"Clin Cancer Res"},{"key":"B170","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2020-001624","article-title":"A systemically deliverable Vaccinia virus with increased capacity for intertumoral and intratumoral spread effectively treats pancreatic cancer","volume":"9","author":"Marelli","year":"2021","journal-title":"J Immunother Cancer"},{"key":"B171","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.3390\/cells8091104","article-title":"Interleukin 21 receptor\/ligand interaction is linked to disease progression in pancreatic cancer","volume":"8","author":"Linnebacher","year":"2019","journal-title":"Cells"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1480496\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T06:43:11Z","timestamp":1738305791000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1480496\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,31]]},"references-count":171,"alternative-id":["10.3389\/fimmu.2025.1480496"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1480496","relation":{},"ISSN":["1664-3224"],"issn-type":[{"type":"electronic","value":"1664-3224"}],"subject":[],"published":{"date-parts":[[2025,1,31]]},"article-number":"1480496"}}